Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Mid Cap Fund median (34 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 28 Nov 2016 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Edelweiss Mid Cap Fund |
|---|---|
| 28 Nov 2016 | ₹100.00 |
| 20 Sep 2017 | ₹131.61 |
| 13 Jul 2018 | ₹136.34 |
| 05 May 2019 | ₹128.07 |
| 25 Feb 2020 | ₹142.07 |
| 17 Dec 2020 | ₹166.80 |
| 09 Oct 2021 | ₹254.39 |
| 01 Aug 2022 | ₹249.69 |
| 24 May 2023 | ₹269.97 |
| 15 Mar 2024 | ₹366.26 |
| 05 Jan 2025 | ₹503.20 |
| 28 Oct 2025 | ₹510.06 |
| 20 Aug 2026 | ₹545.66 |
| Metric | Edelweiss · Regular NAV ₹110.61 Very High risk ★★★★★ | Category median Mid Cap Fund · 34 funds |
|---|---|---|
| +8.55% | +8.71% | |
| +22.28% | +18.06% | |
| +19.09% | +16.16% | |
| — | +15.69% | |
| +19.06% | +16.93% | |
| +19.29% | — | |
| +21.01% | +19.07% | |
| +21.88% | +16.56% | |
| — | +16.43% | |
| Risk | ||
| 16.62% | 16.23% | |
| 0.95 | 0.74 | |
| 1.29 | 1.00 | |
| -41.14% | -37.39% | |
| Nifty Midcap 150 | — | |
| +3.98% | +0.94% | |
| 0.95 | 0.94 | |
| 103.8% | 96.2% | |
| 86.8% | 90.1% | |
| 1.90% | 2.04% | |
| ₹16,310Cr | ₹7,594Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 40% | 41% | |
| Trideep Bhattacharya · 4.9y | — | |
| 28 Nov 2016 | — | |
| 92 | — | |
| 22.4% | — | |
| 0.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.